ZEFFIX

This brand name is authorized in Austria, Australia, Cyprus, Germany, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom

Active ingredients

The drug ZEFFIX contains one active pharmaceutical ingredient (API):

1 Lamivudine UNII 2T8Q726O95 - LAMIVUDINE

Lamivudine is a nucleoside analogue which has activity against human immunodeficiency virus (HIV) and hepatitis B virus (HBV). Its main mode of action is as a chain terminator of viral reverse transcription. Read about Lamivudine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ZEFFIX Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J05AF05	Lamivudine	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
Discover more medicines within J05AF05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10315X
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00587040, 00587057, 01273875, 01517260, 01529665, 01815827, 02028729, 02031625, 02448199, 02448207, 02683581, 02683598
Country: EE	Ravimiamet	Identifier(s): 1043042, 1210161, 1215391
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 99114001, 99114003
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 051508
Country: FR	Base de données publique des médicaments	Identifier(s): 63439683, 68427877
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 139837, 147673, 164497, 375454, 38711
Country: HK	Department of Health Drug Office	Identifier(s): 64011
Country: IE	Health Products Regulatory Authority	Identifier(s): 88260
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4207, 4208
Country: IT	Agenzia del Farmaco	Identifier(s): 034506016
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1003227, 1006258, 1006259
Country: NL	Z-Index G-Standaard	Identifier(s): 14560348
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 53783, 56162
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 8082, 8302
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100093375, 100093381
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65306001, W65306002
Country: SG	Health Sciences Authority	Identifier(s): 11152P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 5463112H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699522096008